Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We will find out soon
EFCT 1-60 split!!! I LOVE IT! EFCT Will be like $7 perfect for a nasdaq uplisting and get rid of manipulators!
EFCT ladies and Gentlemen!
So did they announce the acquisition of which company yet!?? Today is the last day correct?
PPCH to UPLIST!! I need this in my life!!! Lets gooooo!!!
Im out MJMJ and in USMJ!! Cannabis Starbucks Franchise!!
They are also in an article!
As Additional States Prepare for Legalized Marijuana Availability & Operations, New Cannabis Infused Products and Services Are Introduced to Consumer
CORAL SPRINGS, Florida, June 16, 2015 /PRNewswire/ --
The U.S. is the world's largest consumer of hemp products and a recent effort to introduce a new bill to the U.S. Senate targets stopping the unfair punishment of entrepreneurs and farmers who want to be part of a growing cannabis & hemp industry here America. Marijuana, Hemp and Cannabis Companies with current operations in the U.S. in focus today are: North American Cannabis Holdings, Inc. (OTC: USMJ), Totally Hemp Crazy Inc. (OTC: THCZ), Easton Pharmaceuticals Inc. (OTC: EAPH), Terra Tech Corp (OTC: TRTC) and The MaryJane Group, Inc. (OTC:MJMJ)
North American Cannabis Holdings, Inc. (OTC: USMJ) introduces The Starbucks Of Cannabis - The AmeriCanna Café, a new subsidiary founded on the results of an earlier pilot program. The AmeriCanna Café is a destination beverage company designed to let consumers interface with trained staff to learn about the specific benefits of cannabis and to select healthy and refreshing cannabis infused beverages. The menu will include custom blended hemp infused coffee, cold pressed juices and smoothies in addition to carrying raw hemp seeds and other hemp infused foods. As state and federal law permits, THC infused beverages and foods will be added to the menu.
Read the full USMJ Press Release at: http://www.financialnewsmedia.com/profiles/usmj.html
"Ex-Microsoft executive, Jamen Shively, will have some competition in becoming the Starbucks of Cannabis, said North American Cannabis Holdings CEO, Steven Rash. "We've learned a few things in our beverage pilot that we believe give us an edge in the cannabis destination beverage market, not to mention a pending acquisition that once finalized, we believe will give us yet another leg up." The AmeriCanna Café subsidiary is expected to expand rapidly through a national franchise model accelerated by North American Cannabis Holdings' and originates from one of a series of pilots starting back in 2013 under North American Cannabis Holdings' American Seed & Oil Company subsidiary established to conduct various pilots in the legal cannabis sector in order to explore a variety of high growth potential business opportunities.
In other Cannabis/Hemp News And Recent Developments: Totally Hemp Crazy Inc. (OTC: THCZ) announced last week that Avanzar Sales & Distribution, LLC has been appointed as the Southern California Rocky Mountain High distributor. Bill Juarez, President of Avanzar, has consistently demonstrated an innovative vision and has taken Avanzar from startup to the 'Go-To Guy' brand incubator for new product introductions in Southern California.
Easton Pharmaceuticals Inc. (OTC: EAPH) announces yesterday it has closed on the recently announced MOU with BMV Medica S.A. de C.V. to distribute injectable approved cancer drugs from Biolyse Pharma for Mexico and Latin America. The Easton / BMV agreement is under similar terms as previously announced with the Common Sense Inc. agreement for the diagnostic women's health products which maintains a 50/50 net profit sharing on all sales of a line of generic cancer drugs beginning with "Paclitaxel" and "Docetaxel" from St. Catharines, Ontario based Biolyse Pharma Corporation. The terms of the agreement calls for Easton to support the regulatory filings in Mexico for marketing authorization (MA) together with some ancillary costs.
Terra Tech Corp (OTCQB: TRTC) subsidiary, MediFarm announced in early June they are beginning construction within the next 30 days ontheir medical cannabis dispensary located in the City of Las Vegas.MediFarm's 3,900 sq. ft. facility is located adjacent to the LasVegas strip at 1921 Western Avenue. MediFarm originallyreceived a provisional registration certificate from the State ofNevada Department of Health and Human Services Division of Publicand Behavioral Health on 11/3/2014. Subsequently, MediFarmsubmitted its Las Vegas Business License Application to the City ofLas Vegas Department of Planning Business Licensing Division on11/12/14. The Company anticipates all improvements will becompleted and the facility will be serving patients by earlyOctober 2015.
In other Cannabis market activity to note: The MaryJane Group, Inc. (OTCQB:MJMJ) last week debuted CannaCamp: A Bud+Breakfast Mountain Resort - a 170-acre all-inclusive getaway in Durango, Colorado. Just south of the Rocky Mountains and near some of the state's most beloved outdoor destinations, CannaCamp combines recreational marijuana use and education with a traditional ranch experience to create the country's first-ever cannabis resort. MJMJ closed down over 41% on Monday on heavy trading volume over 167Million shares traded by the market close.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand four hundred dollars for news coverage of the current press release issued by North American Cannabis Holdings, Inc. by a non-affiliated company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com
SOURCE FN Media Group LLC
(END)
Whats with all the speculation? MARY JANE GROUP OWNS CANNACAMP AND TWO BED AND BUD BREAKFAST INNS. The camp is being tun by a company partnered with Mary Jane Group called Cultivating Spirits. It's right on the website for both. Some of yalls DD needs hooked on phonics lol
Whats with all the speculation? MARY JANE GROUP OWNS CANNACAMP AND TWO BED AND BUD BREAKFAST INNS. The camp is being tun by a company partnered with Mary Jane Group called Cultivating Spirits. It's right on the website for both. Some of yalls DD needs hooked on phonics lol
CANNACAMP IN USA TODAY!
"America now has a marijuana resort"
http://www.usatoday.com/story/news/nation/2015/06/14/marijuana-resport-america-cannacamp-colorado/71208882/
My PPCH bros. Not promoting at all but MJMJ chart is all too similar to PPCH back in MARCH with initial gap. As well it has just as many supporters as PPCH and great potential just like PPCH. I Believe we may have another small cap bottom that we can get in on. Im already in deep at .004 but the big gains are still there to be made. WATCH! And screen shot. THIS IS MY OFFICIAL CALL!
MMs with their 10k asks to block upward movement. Its really annoying.
CANNACAMP and MJMJ in the New York Times today!!!!
http://www.nytimes.com/2015/06/12/travel/fridays-travel-news-and-tips.html?_r=0
I no they dont. I just wanted clarification on a phrase someone used earlier called a T Trade. Stock babe clarified for me. Thanks tho
Very good read thank you for clearing that up for me!
What the hell is a T Trade?
If it moves to NASDAQ that will give it the exposure it justly deserves! I'm excited as hell and everyone who is in with me should be as well!
EFCT APPLIES FOR UPLISTING! http://ir.efactorgroup.com/all-sec-filings/content/0001615774-15-001458/s101306_s1.htm
IM IN!!
I say Screw it im going in and some dick blocks my .0045 buy smh
Thank you!! Getting greedy lol can I get a .003 area buy in? Haha
Hehe!! YES!! A little lower please!
EFCT is NASDAQ bound people! http://content.stockpr.com/sec/0001615774-15-001449/0001615774-15-001449.pdf
MMs make this baby fall real quick for me please! Thanks!
I sold for a cheap $300 loss. Waitin for this bad boy to hit mid to low .004s and then ima gobble up shares. News coming next week. Im betting 10k it is! Look at the flow of news releases. Every couple days and up to 2 weeks tops!
MaryJane Group Inc (OTCMKTS:MJMJ) And Cultivating Spirits, LLC Enter Into A Consulting Agreement
http://www.journaltranscript.com/2015/06/maryjane-group-inc-otcmktsmjmj-and-cultivating-spirits-llc-enter-into-a-consulting-agreement/
People have been asking my thoughts on EFCT. My truthful unbiased thoughts are. This stock has very little attention. But HUGE potential to be great! My short term vision for it is a steady balance between .04 to .06 for a week or so and then a gap to .1+ within a month where it will stay steady for a few months or until news strikes. Ive been watching this stock for wayyy too long lol
MILLIONS of shares have been recently bought by EFCT insiders! Great sign people! Something big coming!
Someone tried to sell 400k shares at the end of the day *gulp*
PPCH PRICE TARGET OF $1.52!HOLY CRAP!
( PPCH ) SeeThruEquity Initiates Coverage on Propanc Health Group with a Price Target of $1.52
6 hours 11 minutes ago - DJNF
NEW YORK, NY / ACCESSWIRE / May 27, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has initiated coverage of Propanc Health Group Corp.. (PINKSHEETS: PPCH) with a Price Target of $1.52.
The report is available here: PPCH Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's. The report will be available on these platforms. We also contribute our estimates to Thomson Estimates, the leading estimates platform on Wall Street.
"Propanc's pro-enzyme therapy- chiefly its lead drug candidate, PRP- aims to solve this problem by targeting malignant cancer cells through multiple pathways that creates a lasting clinical benefit for the patient. Propanc is now ready to complete the formal animal studies that precede the human trials planned for 2016. Upon commercialization, the drug will be marketed to oncologists across global territories for specific cancer indications aggregating a $9bn total addressable market, " stated Ajay Tandon, CEO of SeeThruEquity. "We are initiating coverage with a 12-month price target of $1.52 per share."
Additional highlights from the report are as follows:
Developing a targeted therapy for metastatic cancer
Propanc's lead drug candidate, PRP, is a once-daily pro-enzyme treatment as a clinically proven therapeutic option in the treatment and prevention of cancer. PRP would be the first therapy of its kind, as there are no FDA approved therapies used for the long-term prevention or management of these conditions. Propanc is focusing on providing oncologists and their patients with more effective metastatic cancer therapies with a substantially reduced side effect profile; specifically, colorectal and pancreatic cancers. Improvement is needed for the standard of care for late stage cancer, with the incumbent treatments causing significant adverse effects for the modest benefits provided.
$9bn market opportunity with an unmet medical need
The rapidly aging population and changing environmental factors in Western countries have spearheaded growing demand for new cancer treatments with increased efficacy and reduced toxicity. Globally, total oncology drug sales are growing 5% annually and reached $91bn in 2013. Additionally, the targeted therapies market segment has substantially increased share over the past decade from 11% to 46%. Propanc is targeting patients with solid tumors- such as colorectal and pancreatic tumors. The total addressable market is estimated to be $7.8bn in 6 years for colorectal cancer, and is expected to grow to $1.63bn by 2017 for pancreatic cancer.
Potential strategic partnership post clinical trial(s)
Propanc is seeking potential licensing partners within the next 12-18 months and the Company is also investigating acquisition opportunities that will expedite their strategic growth and strengthen their portfolio. Company management has stated that once the development projects have sufficiently progressed down the development pathway and have commensurately achieved a major increase in value, they will seek a suitable licensing partner to complete the remaining development activities, obtain regulatory approval and market the product.
Unique intellectual property portfolio with ongoing expansion
Propanc recently filed an international patent application centered on enhancing pro-enzyme formulations and combination therapies comprising trypsinogen and chymotrypsin, and/or other specific anti-cancer agents.
Please review important disclosures on our website at www.seethruequity.com.
About Propanc Health Group Corp
Propanc Health Group is a development stage healthcare company that is currently focused on developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer. Propanc has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors recurring and spreading through the body. The Company's leading products are variations upon novel formulation and involve or employ pro-enzymes, which are inactive precursors of enzymes.
For more information on the Company, its products and services, please visit www.propanc.com.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. We do not conduct any investment banking or commission based business. We are approved to contribute our research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute our research to our database of opt-in investors. We also contribute our estimates to Thomson Estimates, the leading estimates platform on Wall Street.
For more information visit www.seethruequity.com.
Contact:
Ajay Tandon
SeeThruEquity
info@seethruequity.com
SOURCE: SeeThruEquity
(END) Dow Jones Newswires
First Quarter 2015 Highlights and CEO Commentary
- Consolidated revenues increase 7.6x to a record $1,003,641
- Social Networks division revenues increases 20.1x to $485,157
- Business Services division increases 4.5x to $518,484
FIRST QUARTER FINANCIALS ARE IN AND REVENUE HAS JUMPED 10x!!! I LOVE THIS COMPANY!
PPCH financials this quarter will be good and people dont realize it lol. They settled debts, received funding, and made a partnership this quarter! Lmfao financially those are all plusses that weren't seen in any prior quarter. Let the money roll in for all those who were smart enough to stay in and buy more like myself. I have a .045 avg tomorrow IM EATING!
FIRST QT FINANCIALS TOMORROW!!! LET THE FUN BEGIN!! $$$$!
How much yall want to bet there will be a pleasant surprise in the 10Q lmfaoo! PPCH is a sneaky bastard. Watch tomorrow go GREEN
This will either make you rich or put you in the poor house. Positive News is the deciding factor. That is all! Im in deep and only down $300 at close because of smart buys but damn if we don't get some positive news in the next 2 weeks.
Bought more at .048 I hope it drops to .04 before the end of the month so I can buy more before the conference hits. This shit is gonna go LOCO!
This reverse split some of the best news yet! Get this company out the OTC and into the eyes of real investors not the pink sheet manipulators. Never seen such a good company get dogged like EFCT.
No its not in any way. You're ridiculous. You must have a short position smh
Tomorrow we will see $3! Im ready for more money!